Public Sector Pension Investment Board Amgen Inc Transaction History

Public Sector Pension Investment Board

$15.9 Billion
Q2 2024

A detailed history of Public Sector Pension Investment Board transactions in Amgen Inc stock. As of the latest transaction made, Public Sector Pension Investment Board holds 20,647 shares of AMGN stock, worth $6.52 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

20,647

Previous 11,852 74.21%

Holding current value

$6.52 Million

Previous $3.37 Million 91.48%

% of portfolio

0.04%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $2.31 Million - $2.81 Million	8,795 Added 74.21%	20,647 $6.45 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $80,661 - $97,368	-300 Reduced 2.47%	11,852 $3.37 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $11.5 Million - $13 Million	-45,145 Reduced 78.79%	12,152 $3.5 Million
Q3 2023 Nov 22, 2023	BUY	$218.65 - $271.46 $1.34 Million - $1.66 Million	6,132 Added 11.98%	57,297 $15.4 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $1.63 Million - $1.92 Million	-7,584 Reduced 12.91%	51,165 $11.4 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $1.73 Million - $2.11 Million	-7,681 Reduced 11.56%	58,749 $14.2 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $2.08 Million - $2.64 Million	9,089 Added 15.85%	66,430 $17.4 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.34 Million - $1.51 Million	5,957 Added 11.59%	57,341 $12.9 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $6.38 Million - $7.1 Million	-27,647 Reduced 34.98%	51,384 $12.5 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $3.28 Million - $3.63 Million	-14,960 Reduced 15.92%	79,031 $19.1 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $443,502 - $507,548	-2,230 Reduced 2.32%	93,991 $21.1 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $1.23 Million - $1.44 Million	5,784 Added 6.4%	96,221 $20.5 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $8.37 Million - $9.28 Million	35,816 Added 65.57%	90,437 $22 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $4.08 Million - $4.76 Million	-18,400 Reduced 25.2%	54,621 $13.6 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $5.42 Million - $6.46 Million	-25,070 Reduced 25.56%	73,021 $16.8 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $9.69 Million - $10.8 Million	41,300 Added 72.72%	98,091 $24.9 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $8.43 Million - $10.3 Million	-42,600 Reduced 42.86%	56,791 $13.4 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $14.3 Million - $19 Million	-78,418 Reduced 44.1%	99,391 $20.2 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $11.6 Million - $14.9 Million	61,358 Added 52.69%	177,809 $42.9 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $6.41 Million - $7.68 Million	36,795 Added 46.19%	116,451 $22.5 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $4.62 Million - $5.41 Million	27,700 Added 53.31%	79,656 $14.7 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $3.36 Million - $3.79 Million	18,600 Added 55.76%	51,956 $9.87 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $517,360 - $603,925	2,900 Added 9.52%	33,356 $6.49 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $1.28 Million - $1.44 Million	-6,900 Reduced 18.47%	30,456 $6.31 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $8.06 Million - $9.42 Million	-47,600 Reduced 56.03%	37,356 $6.37 Million
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $19.6 Million - $22 Million	-116,400 Reduced 57.81%	84,956 $14.8 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $33.7 Million - $38.5 Million	201,356	201,356 $0

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.

Account

Public Sector Pension Investment Board Amgen Inc Transaction History